Treace Medical Concepts (TMCI) Gross Profit (2020 - 2026)

Treace Medical Concepts' Gross Profit history runs 7 years deep, the most recent figure standing at $37.4 million for Q1 2026.

• Quarterly Gross Profit fell 10.71% year-over-year to $37.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $165.3 million (down 2.31% YoY) and the FY2025 annual result came in at $169.8 million, up 0.88% from the prior year.
• Gross Profit was $37.4 million for Q1 2026 at Treace Medical Concepts, down from $50.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $55.5 million in Q4 2024 and bottomed at $23.9 million in Q1 2022.
• A 5-year average of $37.9 million and a median of $37.4 million in 2026 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit soared 55.51% — and 2026, when it declined 10.71%.
• Treace Medical Concepts' Gross Profit stood at $40.7 million in 2022, then grew by 24.53% to $50.7 million in 2023, then rose by 9.33% to $55.5 million in 2024, then slipped by 9.15% to $50.4 million in 2025, then slipped by 25.78% to $37.4 million in 2026.
• Business Quant data shows TMCI's Gross Profit at $37.4 million in Q1 2026, $50.4 million in Q4 2025, and $39.7 million in Q3 2025.